This is because a more profound defect in TLR pathway defects in patients with CVID with biallelic variants in TACI provides protection against development of autoimmunity even though autoreactive B cells are also increased in patients with biallelic variants in TACI (63). This evidence concerns the gene TNFRSF13B and Autoimmunity.